Increxxa
|
Control and Treat BRD with Lasting Confidence
Treatment of BRD and control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Treatment of infectious bovine keratoconjunctivitis associated with Moraxella bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii. In cattle, inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) body weight. Do not inject more than 10 mL per injection site. |
|
Additional Product Information
|
|
INQUIRY FORM
